ADAPT Trial Data - 09/08/11
Doi : 10.1016/j.amjmed.2006.09.022
John Breitner, MD, MPH a : Chair of ADAPT, Denis Evans, MD b : Chair, ADAPT Steering Committee, Constantine Lyketsos, MD, MPH c : Field Site Director, Barbara Martin, PhD : Deputy Director, ADAPT Coordinating Center, Curtis Meinert, PhD d : Director, ADAPT Coordinating Center
a VA Puget Sound Health Care System and Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, Wash
b Rush Institute for Healthy Aging, Rush University, Chicago, Ill
c Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD
d Center for Clinical Trials, Department of Epidemiology, Johns Hopkins University, Bloomberg School of Public Health, Baltimore, MD
El texto completo de este artículo está disponible en PDF.
© 2007
Elsevier Inc. Reservados todos los derechos.
Vol 120 - N° 3
P. e3 - mars 2007 Regresar al número
Artículo precedente
- Risedronate-induced Hepatitis
- Michael B. Phillips
- The Reply
- Shelley R. Salpeter, Eric J. Topol
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?